Expression of COX-2 and steroid converting enzymes in breast cancer

  • Authors:
    • Cecilia Gunnarsson
    • Agneta Jansson
    • Birgitta Holmlund
    • Lilianne Ferraud
    • Bo Nordenskjöld
    • Lars Erik Rutqvist
    • Lambert Skoog
    • Olle Stål
  • View Affiliations

  • Published online on: August 1, 2006     https://doi.org/10.3892/or.16.2.219
  • Pages: 219-224
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

COX-2 is upregulated in many breast tumors, and one of the products of COX-2 is PGE2 that is suggested to upregulate aromatase through cAMP signaling in breast cancer. Although aromatase can increase the estrogen levels in tumors, 17β-hydroxysteroid dehydrogenase (17HSD) activity is finally needed for the estrone/estradiol regulation. The aim of this study was to investigate if the protein expression of enzymes involved in estrogen synthesis shows covariation with the expression of COX-2. We also wanted to correlate these results with prognosis. We analyzed the expression of COX-2, aromatase, 17HSD1 and 17HSD2 with immunohistochemistry using tissue microarrays composed of 356 primary breast tumors. In the present study COX-2 was correlated to aromatase (P<0.00001), 17HSD1 (P=0.0073), and 17HSD2 (P<0.00001). Patients with ER positive tumors expressing low amounts of 17HSD2 had decreased breast cancer survival (P=0.013). Elevated expression of COX-2 and aromatase was more frequent among larger tumors (P=0.017 and P=0.013). COX-2 expression correlates with the levels of the examined steroid converting enzymes and may contribute to increased estrogen levels in the tumor. In breast cancer cells, the regulatory function of 17HSD2 could be lost, and in the present study patients with low or non-detectable levels of 17HSD2 had worse prognosis than had breast cancer patients with higher levels of the enzyme.

Related Articles

Journal Cover

August 2006
Volume 16 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gunnarsson C, Jansson A, Holmlund B, Ferraud L, Nordenskjöld B, Rutqvist LE, Skoog L and Stål O: Expression of COX-2 and steroid converting enzymes in breast cancer. Oncol Rep 16: 219-224, 2006
APA
Gunnarsson, C., Jansson, A., Holmlund, B., Ferraud, L., Nordenskjöld, B., Rutqvist, L.E. ... Stål, O. (2006). Expression of COX-2 and steroid converting enzymes in breast cancer. Oncology Reports, 16, 219-224. https://doi.org/10.3892/or.16.2.219
MLA
Gunnarsson, C., Jansson, A., Holmlund, B., Ferraud, L., Nordenskjöld, B., Rutqvist, L. E., Skoog, L., Stål, O."Expression of COX-2 and steroid converting enzymes in breast cancer". Oncology Reports 16.2 (2006): 219-224.
Chicago
Gunnarsson, C., Jansson, A., Holmlund, B., Ferraud, L., Nordenskjöld, B., Rutqvist, L. E., Skoog, L., Stål, O."Expression of COX-2 and steroid converting enzymes in breast cancer". Oncology Reports 16, no. 2 (2006): 219-224. https://doi.org/10.3892/or.16.2.219